Download | < Back |
05 Aug 2022 | |
We wish to inform that the USFDA conducted an inspection of our Moraiya manufacturing facility located at Ahmedabad from 26th July to 5th August, 2022. The inspection concluded with four Form 483 observations. None of the observations were related to data integrity. The Company will address the observations within the stipulated timeline. | |
View all announcements for Zydus Lifesciences Ltd | Source: BSE India |